> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Info Collection on Postmarket Drug Reporting
- URL: https://www.fdaweb.com/info-collection-on-postmarket-drug-reporting/
- Published: 2018-11-07T12:00:00.000Z
- Updated: 2026-09-15T00:43:06.000Z
- Author: David McFarland
- Tags: FDA Policy/General, #legacy-id-D5142770

*Federal Register* notice: FDA has submitted to OMB a revised information collection on “Postmarketing Adverse Drug and Biological Product Experience Reporting and Recordkeeping” (OMB Control Number 0910-0230). To view the notice, click [here](https://s3.amazonaws.com/public-inspection.federalregister.gov/2018-24442.pdf?ref=fdaweb.com).